A Comparative Clinical Study to Evaluate the Effect of Sigru Leaf Powder and Sigru Bark Powder in the Management of Sannipatika Pandu with Reference to Sickle Cell Anemia

Authors

  • Sudipta Bez P. G. Scholar, Department of Roga Nidan Evam Vikriti Vigyana, Government Ayurvedic College and Hospital, Balangir, Odisha, India. Author
  • Utkalini Nayak Reader, Department of Roga Nidana Evam Vikriti Vigyana, Government Ayurvedic College and Hospital, Balangir, Odisha, India. Author
  • Pradip Kumar Panda Professor and Dean, Department of Roga Nidana Evam Vikriti Vigyana, SSCAS and RH, Sri Sri University, Cuttack, Odisha, India. Author
  • Manoranjan Sahu Lecturer, P.G, Department of Roga Nidana Evam Vikriti Vigyana,Government Ayurvedic College and Hospital, Balangir, Odisha, India. Author
  • Amrit Dutta P.G.M.D, Department of Physiology, JNMC, Belgavi, Karnataka, India. Author

DOI:

https://doi.org/10.48165/IRJAY.2024.70101

Keywords:

Sannipatika Pandu, Sickle cell anemia, Sigru bark powder, Sigru leaf powder

Abstract

Background: Various ailments are related to Panduroga, either as a symptom or as an Upadrava, according to  Ayurvedic literature. The present clinical study is a humble effort to assess the effect of the trial drug, Sigru leaves  powder and Sigru bark powder on Sannipatika Pandu (sickle cell anemia). Materials and Methods: A total of 30 patients of Sannipatika Pandu (sickle cell anemia) were taken for the present  study, 15 patients each in Group A (Trial Group-1) and Group B (Trial Group-2). This is a clinicopathological study  (single-blind study). Group A (Trial Group-1): 15 patients were treated with Sigru leaves powder 3 g twice daily with  water for 30 days after food. Group B (Trial Group-2): 15 patients were treated with Sigru bark powder 3 g twice  daily with water for 30 days after food. Results and Discussion: As per the statistical tests, we can conclude that there is no significant change observed in  Group A and Group B. Conclusion: It is found that the trial medications can be safely supplied to everyone for an extended period of time  and may offer the best chance of recovery for sickle cell anemia.

Downloads

Download data is not yet available.

References

Triapthy B. Charaka Chikitsa. 16-4/6, Hindi Commentary. 2012th ed. Delhi: Chaukhamba Sanskrit Pratishthan; 1982.

p. 2275.

Triapthi B. Charak Samhita-“Charaka-Chandrika” Hindi Commentary Cha.Chi.16/26. Delhi: Chaukhamba Sanskrit Pratishthan; 2012. p67.

Triapthi B. Charak Samhita-“Charaka-Chandrika” Hindi Commentary Ch.su.23/5. Delhi Chaukhamba Sanskrit Pratishthan; 2012. p.54.

Acharya YT. Susruta Samhita- “Ayurveda-Tattva-Sandipika” Hindi Commentary Su. Utt.44/3. Delhi: Chaukhamba Sanskrit Pratishthan; 2012. p23.

Triapthi B. Astanga Hrdayam-“Nirmala” Hindi Commentary edition. Delhi: Chaukhamba Sanskrit Pratishthan; 2013.

Das LK, Padhi B, Sahu SS. Prediction of outcome of severe falciparum malaria in Koraput, Odisha, India: A hospital-based study. Trop Parasitol 2014;4:105-10.

Karna B, Jha SK, Al Zaabi E. Hemoglobin C disease. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2020.

Downloads

Published

2024-01-31

How to Cite

Bez, S., Nayak, U., Panda, P. K., Sahu, M., & Dutta, A. (2024). A Comparative Clinical Study to Evaluate the Effect of Sigru Leaf Powder and Sigru Bark Powder in the Management of Sannipatika Pandu with Reference to Sickle Cell Anemia . International Research Journal of Ayurveda & Yoga, 7(1), 1-8. https://doi.org/10.48165/IRJAY.2024.70101